Efficacy of omarigliptin, once-weekly dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes

Omarigliptin is one of several once-weekly dipeptidyl peptidase-4 inhibitors (DPP-4is). Despite the high frequency of switching from various daily DPP-4is to omarigliptin in actual clinical practice, data regarding its efficacy in patients with type 2 diabetes (T2D) after switching are limited. To a...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	World journal of diabetes 2021-12, Vol.12 (12), p.2087-2095
Hauptverfasser:	Kawasaki, Eiji, Nakano, Yuko, Fukuyama, Takahiro, Uchida, Aira, Sagara, Yoko, Tamai, Hidekazu, Tojikubo, Masayuki, Hiromatsu, Yuji, Koga, Nobuhiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Retrospective Study
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!